Medical Properties Gets a Buy Rating from Jefferies

By Carrie Williams

Jefferies analyst Omotayo Okusanya reiterated a Buy rating on Medical Properties (NYSE: MPW) yesterday and set a price target of $15. The company’s shares opened today at $12.81.

According to, Okusanya is a 4-star analyst with an average return of 6.3% and a 59.0% success rate. Okusanya covers the Financial sector, focusing on stocks such as Government Properties Income Trust, National Storage Affiliates Trust, and Retail Properties of America Inc.

Medical Properties has an analyst consensus of Moderate Buy, with a price target consensus of $14.60.

Based on Medical Properties’ latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $167 million and quarterly net profit of $73.32 million. In comparison, last year the company earned revenue of $126 million and had a net profit of $53.59 million.

Based on the recent corporate insider activity of 22 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed to focus on investing in and owning net-leased healthcare facilities across the United States of America and selective foreign countries. Its activities include acquisition and development of healthcare facilities and lease the facilities to healthcare operating companies under long-term net leases. It also involved in mortgage loans to healthcare operators collateralized by their real estate assets. The company was founded by Edward K. Aldag Jr., R. Steven Hamner, Emmett E McLean, and William G. McKenzie on August 27, 2003 and is headquartered in Birmingham, AL.